[Present state of the multidisciplinary treatment of renal, bladder and prostatic tumors].
Surgery has been considered to be a main treatment of urogenital cancer. However, surgery alone could not completely cure these patients. The prognosis was poor. Multi-disciplinary treatment has been adopted to improve these results. However, there are many problems to be solved, such as combination of these regimens. In addition, the criteria for evaluation of the therapy should be considered. Nevertheless, multi-disciplinary treatment has been one of the most potent procedures for these malignancies.
D000230:Adenocarcinoma / Q000188:drug therapy / Q000628:therapy*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D004621:Embolization, Therapeutic; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000628:therapy*; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D011879:Radiotherapy Dosage; D012077:Renal Artery; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*